Unicycive Therapeutics News

Unicycive Therapeutics | 8-K: Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

May 13 16:29 ET

Unicycive Therapeutics | DEFA14A: Others

May 8 16:11 ET

Unicycive Therapeutics | DEF 14A: Definitive information statements

Apr 26 17:15 ET

Unicycive Therapeutics | DEFA14A: Others

Apr 26 17:15 ET

Unicycive Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 16:13 ET

Unicycive Therapeutics | 8-K: Current report

Mar 29 13:28 ET

Unicycive Therapeutics | 8-K: Current report

Mar 14 16:31 ET

Unicycive Therapeutics | 8-K: Current report

Mar 14 16:05 ET

Unicycive Therapeutics | 8-K: Current report

Feb 21 16:12 ET

Unicycive Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 8, 2023 16:36 ET

Unicycive Therapeutics | 8-K: Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 14, 2023 16:42 ET

Unicycive Therapeutics | 8-K: Current report

Oct 23, 2023 11:12 ET

Unicycive Therapeutics | 8-K: Current report

Sep 25, 2023 16:05 ET

Unicycive Therapeutics | 8-K: Current report

Sep 6, 2023 09:16 ET

Unicycive Therapeutics | 8-K: Current report

Aug 31, 2023 16:16 ET

Unicycive Therapeutics | 8-K: Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 14, 2023 21:19 ET

Unicycive Therapeutics | 8-K: Current report

Jul 31, 2023 16:15 ET

Unicycive Therapeutics | 8-K: Current report

Jul 26, 2023 06:05 ET

Unicycive Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jul 12, 2023 19:49 ET

Unicycive Therapeutics | 8-K: Current report

Jun 29, 2023 17:50 ET